Literature DB >> 12867630

The vascular lesions of a cow and bison with sheep-associated malignant catarrhal fever contain ovine herpesvirus 2-infected CD8(+) T lymphocytes.

Susan Simon1, Hong Li2, Donal O'Toole3, Timothy B Crawford1, J Lindsay Oaks1.   

Abstract

Malignant catarrhal fever (MCF) is a herpesvirus disease syndrome of ruminants. The microscopic pathology of MCF is characterized by lymphoid proliferation and infiltration, necrotizing vasculitis and epithelial necrosis. Because previous attempts to detect viral antigen or nucleic acids in lesions have been unsuccessful, the pathogenesis of the lesions in acute MCF has been speculated to involve mechanisms of autoimmunity and lymphocyte dysregulation. In this study, the vascular lesions in the brains of a cow and a bison with acute MCF were evaluated by in situ PCR and immunohistochemistry. The results demonstrated that the predominant infiltrating cell type in these lesions was CD8(+) T lymphocytes and that large numbers of these cells were infected with ovine herpesvirus 2. The lesions also contained macrophages, but no detectable CD4(+) or B lymphocytes.

Entities:  

Mesh:

Year:  2003        PMID: 12867630     DOI: 10.1099/vir.0.19048-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  10 in total

1.  Ovine Herpesvirus 2 Glycoproteins B, H, and L Are Sufficient for, and Viral Glycoprotein Ov8 Can Enhance, Cell-Cell Membrane Fusion.

Authors:  Salim M AlHajri; Cristina W Cunha; Anthony V Nicola; Hector C Aguilar; Hong Li; Naomi S Taus
Journal:  J Virol       Date:  2017-02-28       Impact factor: 5.103

2.  Differential transcription of ovine herpesvirus 2 genes in lymphocytes from reservoir and susceptible species.

Authors:  Leenadevi Thonur; George C Russell; James P Stewart; David M Haig
Journal:  Virus Genes       Date:  2006-02       Impact factor: 2.332

3.  Duration of protective immunity and antibody responses in cattle immunised against alcelaphine herpesvirus-1-induced malignant catarrhal fever.

Authors:  George C Russell; Julio Benavides; Dawn Grant; Helen Todd; David Deane; Ann Percival; Jackie Thomson; Maira Connelly; David M Haig
Journal:  Vet Res       Date:  2012-06-11       Impact factor: 3.683

4.  Malignant catarrhal fever induced by Alcelaphine herpesvirus 1 is characterized by an expansion of activated CD3+CD8+CD4- T cells expressing a cytotoxic phenotype in both lymphoid and non-lymphoid tissues.

Authors:  Benjamin G Dewals; Alain Vanderplasschen
Journal:  Vet Res       Date:  2011-08-22       Impact factor: 3.683

Review 5.  Malignant catarrhal fever: understanding molecular diagnostics in context of epidemiology.

Authors:  Hong Li; Cristina W Cunha; Naomi S Taus
Journal:  Int J Mol Sci       Date:  2011-10-18       Impact factor: 5.923

Review 6.  Important mammalian veterinary viral immunodiseases and their control.

Authors:  J R Patel; J G M Heldens; T Bakonyi; M Rusvai
Journal:  Vaccine       Date:  2012-01-17       Impact factor: 3.641

7.  Ovine herpesvirus 2 infection in Foal, Brazil.

Authors:  Erica A Costa; Maria Rosa Q Bomfim; Flávio G da Fonseca; Betânia P Drumond; Fabiana Magalhães Coelho; Anilton C Vasconcelos; Ronaldo Furtini; Tatiane A Paixão; Renee M Tsolis; Renato L Santos; Mauricio Resende
Journal:  Emerg Infect Dis       Date:  2009-05       Impact factor: 6.883

8.  Malignant catarrhal fever induced by alcelaphine herpesvirus 1 is associated with proliferation of CD8+ T cells supporting a latent infection.

Authors:  Benjamin Dewals; Christel Boudry; Frédéric Farnir; Pierre-Vincent Drion; Alain Vanderplasschen
Journal:  PLoS One       Date:  2008-02-20       Impact factor: 3.240

9.  The effect of the TLR9 ligand CpG-oligodeoxynucleotide on the protective immune response to alcelaphine herpesvirus-1-mediated malignant catarrhal fever in cattle.

Authors:  Nevi Parameswaran; George C Russell; Kathryn Bartley; Dawn M Grant; David Deane; Helen Todd; Mark P Dagleish; David M Haig
Journal:  Vet Res       Date:  2014-05-27       Impact factor: 3.683

10.  A field vaccine trial in Tanzania demonstrates partial protection against malignant catarrhal fever in cattle.

Authors:  F Lankester; G C Russell; A Lugelo; A Ndabigaye; N Mnyambwa; J Keyyu; R Kazwala; D Grant; A Percival; D Deane; D M Haig; S Cleaveland
Journal:  Vaccine       Date:  2015-12-17       Impact factor: 3.641

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.